Back
Elite Pharmaceuticals Vs. Verrica Pharmaceuticals Industry Stock Comparison
Buy
51
ELTP
Elite Pharmaceuticals
Last Price:
0.58
Seasonality Move:
15.32%
Sell
40
VRCA
Verrica Pharmaceuticals
Last Price:
1.22
Seasonality Move:
50.53%
Buy
51
Elite Pharmaceuticals (ELTP)
is a Buy
Is Elite Pharmaceuticals a Buy, Sell or Hold?
- The current Elite Pharmaceuticals [ELTP] share price is $0.59. The Score for ELTP is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
- ELTP is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
40
Verrica Pharmaceuticals (VRCA)
is a Sell
Is Verrica Pharmaceuticals a Buy, Sell or Hold?
- The current Verrica Pharmaceuticals [VRCA] share price is $1.11. The Score for VRCA is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
- VRCA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ELTP Stock Price Chart
What is Elite Pharmaceuticals's stock price today?
-
The Elite Pharmaceuticals share price today is $0.59
The current trend is moderately bullish and ELTP is experiencing slight selling pressure.
VRCA Stock Price Chart
What is Verrica Pharmaceuticals's stock price today?
-
The Verrica Pharmaceuticals share price today is $1.11
The current trend is relatively stagnant and VRCA is experiencing buying pressure, which is a positive indicator for future bullish movement.
ELTP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.04 | Buy |
| Relative Strength Index (14 RSI): | 54.28 | Buy |
| Chaikin Money Flow: | -279077 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.49 - 0.61) | Buy |
| Bollinger Bands (100): | (0.21 - 0.51) | Buy |
VRCA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.13 | Sell |
| Relative Strength Index (14 RSI): | 48.94 | Sell |
| Chaikin Money Flow: | 737946 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.8 - 1.44) | Sell |
| Bollinger Bands (100): | (0.62 - 5.5) | Sell |
ELTP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.62 | Sell |
| 20-day SMA: | 0.56 | Buy |
| 50-day SMA: | 0.49 | Buy |
| 200-day SMA: | 0.26 | Buy |
| 8-day EMA: | 0.6 | Sell |
| 20-day EMA: | 0.57 | Buy |
| 50-day EMA: | 0.49 | Buy |
| 200-day EMA: | 0.3 | Buy |
VRCA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.95 | Buy |
| 20-day SMA: | 1.01 | Buy |
| 50-day SMA: | 1.32 | Sell |
| 200-day SMA: | 4.97 | Sell |
| 8-day EMA: | 0.99 | Buy |
| 20-day EMA: | 1.05 | Buy |
| 50-day EMA: | 1.58 | Sell |
| 200-day EMA: | 3.93 | Sell |
Elite Pharmaceuticals Earnings Growth & ELTP Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Verrica Pharmaceuticals Earnings Growth & VRCA Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.25 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.03 per share, and an increase next year of $0.82 per share.
Elite Pharmaceuticals Technical Analysis
| Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Verrica Pharmaceuticals Technical Analysis
| Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||